Overview

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if emtricitabine is safe in children infected with HIV and to determine the best dose.
Phase:
Phase 2
Details
Lead Sponsor:
Triangle Pharmaceuticals
Treatments:
Anti-Retroviral Agents
Emtricitabine
Lopinavir
Ritonavir
Stavudine